Male | Female | P value | |
---|---|---|---|
N=786 | N=1432 | ||
Age mean (SD) | 61.6 (13.2) | 58.1 (15.1) | 0* |
Smoker % | 28 | 21 | 0** |
Social deprivation decile mean (SD) | 5.4 (2.9) | 5.5 (2.9) | 0.6** |
Seropositive % | 66 | 70 | 0.05** |
symptom duration days | 230 | 226 | 0.8* |
Baseline DAS-28 mean (SD) | 5.1 (1.4) | 5.3 (1.3) | 0.03* |
FU DAS-28 mean (SD) | 3.3 (1.5) | 3.6 (1.5) | 0.0001* |
Change in DAS-28 mean (SD) | 1.8 (1.7) | 1.7 (1.6) | 0.08* |
EULAR good response % | 43.4 | 36.7 | 0.002** |
Timely referral % | 16 | 15 | 0.3** |
Timely rheumatology assessment % | 39 | 39 | 0.7** |
Steroids commenced at baseline % | 87 | 86 | 0.7** |
Early DMARD treatment % | 28 | 27 | 0.9** |
Any DMARD prescribed within 6 weeks % | 70 | 70 | 0.9** |
DMARD choice; Methotrexate monotherapy % | 69 | 68 | 0.6** |
DMARD choice; combination therapy % | 44 | 44 | 0.8** |
*t-test **chi-squared. Social deprivation decile from deprivation rank calculated via super output area.